As of 2026-09-09, the Fair Value of Faron Pharmaceuticals Oy (FARN.L) is -58.44 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 35.00 GBP, the upside of Faron Pharmaceuticals Oy is -266.96%.
With the market price of 35.00 GBP and our fair value calculation, Faron Pharmaceuticals Oy (FARN.L) is not a good investment. Investing in FARN.L stocks now will result in a potential loss of 266.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -21.21 | -28.73 | -30.94 | -25.92 | -27.26 | -26.81 |
| YoY growth | -25.16% | -35.46% | -7.71% | 16.24% | -5.16% | -11.45% |
| Market Cap (mil) | 69.86 |
| P/E | |
| Forward P/E |
| EPS | -13.66 |
| Avg earnings growth rate | -11.45% |
| TTM earnings | -27.26 |